Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapy.
We report the case of a 2-year-old boy with immune thrombocytopenia (ITP) who developed fatal intracranial hemorrhage (ICH) despite maximum therapy according to the guidelines. Hitherto defined risk factors do not predict severe or atypical courses.
Uetz
B
B
Technische Universität München, Department of Pediatrics and Pediatric Oncology Center, Kölner Platz 1, Munich, Germany. Barbara.Uetz@lrz.tu-muenchen.de
Wawer
A
A
Nathrath
M
M
Burdach
S
S
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003399:Craniotomy; D018450:Disease Progression; D017707:Erythrocyte Transfusion; D017809:Fatal Outcome; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D020300:Intracranial Hemorrhages / Q000628:therapy*; D008297:Male; D010976:Platelet Count; D017713:Platelet Transfusion; D011239:Prednisolone / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D012307:Risk Factors
D000893:Anti-Inflammatory Agents; D007074:Immunoglobulin G; D011239:Prednisolone